Your session is about to expire
← Back to Search
Neurostimulation for Mild Cognitive Impairment (PAS-MCI Trial)
PAS-MCI Trial Summary
This trial is testing a neurostimulation approach to see if it can enhance prefrontal cortical plasticity and function in patients with MCI, in an effort to find a treatment modality that could potentially prevent progression to AD.
PAS-MCI Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPAS-MCI Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PAS-MCI Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with mild cognitive impairment due to Alzheimer's.I have a mental health condition that affects my brain's decision-making area.I am on anticonvulsants for chronic pain, with a stable dose for 4 weeks.You have a history of mental health diagnoses, excluding simple or specific phobias, or any condition that may affect the front part of your brain.I am currently taking medication for memory problems.I am 60 years old or older.I have been experiencing symptoms of major depression in the last 3 months.I am currently taking medication for seizures.My cognitive issues are not due to any injury, blood vessel problems, or other medical conditions.I am currently taking medication for a brain or nerve condition.I have been diagnosed with mild cognitive impairment due to Alzheimer's disease.I take more than 2 mg/day of a medication similar to lorazepam.I am 60 years old or older.I use more than the equivalent of 2 mg/day of lorazepam.I have been diagnosed with mild cognitive impairment due to Alzheimer's.I am 60 years old or older.
- Group 1: PAS-Control (PAS-C)
- Group 2: Healthy Control
- Group 3: Active PAS
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals will be included in the research project?
"Affirmative. According to the clinicaltrials.gov, this study is currently enrolling participants with a first posting date of October 12th 2020 and most recent update as August 9th 2022. The trial needs 150 patients at one site for completion."
Are any enrollees being accepted for this experiment presently?
"That is correct. Clinicaltrials.gov states that this clinical trial, originally posted on October 12th 2020, is actively seeking volunteers. 150 individuals are required to be enrolled from a single medical centre."
Share this study with friends
Copy Link
Messenger